Practical Guidance on [<superscript>177</superscript>Lu]Lu-PSMA-617 Treatment, Including Radiation Safety, Adverse Event Monitoring, and Patient Counseling.
In: Clinical Journal of Oncology Nursing, Jg. 27 (2023-10-01), Heft 5, S. 539-547
academicJournal
Zugriff:
BACKGROUND: The approval of the prostatespecific membrane antigen (PSMA)-targeted radioligand therapy [177Lu]Lu-PSMA-617 represents a shift toward precision medicine-based treatments for metastatic castration-resistant prostate cancer. OBJECTIVES: This review aims to provide practical advice and clinical considerations for working with [177Lu]Lu-PSMA-617; particularly, regarding the role of nurses in managing radiation safety, monitoring and reporting of adverse events, and counseling patients receiving this therapy. METHODS: Clinical data, protocols, and guidelines are summarized alongside real-world insights to provide practical recommendations for nurses caring for patients treated with [177Lu]Lu-PSMA-617. FINDINGS: Nurses coordinate safe care for patients receiving [177Lu]Lu-PSMA-617 by facilitating communication among physicians, managing logistic concerns, monitoring for adverse events related to treatment, providing education, and counseling patients and caregivers throughout treatment. [ABSTRACT FROM AUTHOR]
Titel: |
Practical Guidance on [<superscript>177</superscript>Lu]Lu-PSMA-617 Treatment, Including Radiation Safety, Adverse Event Monitoring, and Patient Counseling.
|
---|---|
Autor/in / Beteiligte Person: | Spitz, Avery ; Floyd, Rebecca ; Sutton, Jennifer ; Gardner, Linda |
Zeitschrift: | Clinical Journal of Oncology Nursing, Jg. 27 (2023-10-01), Heft 5, S. 539-547 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1092-1095 (print) |
DOI: | 10.1188/23.CJON.539-547 |
Schlagwort: |
|
Sonstiges: |
|